HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$14.89
Day range
$13.96 - $14.69
Year range
$13.96 - $73.00
Market cap
589.79M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 388.00K | 4,750.00% |
Operating expense | 9.82M | 7.35% |
Net income | -52.96M | -34.27% |
Net profit margin | -13.65K | 97.23% |
Earnings per share | -1.41 | -6.02% |
EBITDA | -58.34M | -35.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 530.68M | 84.33% |
Total assets | 579.27M | 77.56% |
Total liabilities | 46.44M | 52.72% |
Total equity | 532.84M | — |
Shares outstanding | 40.51M | — |
Price to book | 1.10 | — |
Return on assets | -28.36% | — |
Return on capital | -29.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -52.96M | -34.27% |
Cash from operations | -30.50M | 10.25% |
Cash from investing | -386.00K | 29.82% |
Cash from financing | 155.94M | 54,809.86% |
Net change in cash | 125.06M | 465.15% |
Free cash flow | -15.43M | 32.77% |
About
Founded
2015
Headquarters
Website
Employees
160
